Allergan Launches Viberzi In U.S. For Irritable Bowel Syndrome With Diarrhea

(RTTNews) - Allergan plc (AGN), said that Viberzi, or exadoline, the company's first-in-class treatment for irritable bowel syndrome with diarrhea or IBS-D, is now available by prescription in the U.S.

IBS-D is a multifactorial disorder marked by recurrent abdominal pain or discomfort and diarrhea that affects as many as 15 million adult Americans, impacting both women and men equally.

Viberzi is an oral medication that relieves the core symptoms of IBS-D, diarrhea and abdominal pain. Symptom relief was maintained throughout treatment in two pivotal clinical trials.